Leap Therapeutics to Host Virtual KOL Event to Discuss Sirexatamab (DKN-01) in Second-line Patients with Advanced Microsatellite Stable Colorectal Cancer

Stock Information for Q32 Bio Inc Com

Loading

Please wait while we load your information from QuoteMedia.